EUVIMEDEUVIMED entdecken
Crossref

Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme

Ke Du, Xiao Li, Fude Feng iD

ACS Applied Bio Materials · 18.03.2024 · 7 (3) · 1810-1819

DOI: 10.1021/acsabm.3c01219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 26.02.2024. Verfasst von Ke Du und 2 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of High Performance Polymer Materials and Technology, and Department of Polymer Science & Engineering, School of Chemistry & Chemi…. Hauptthemen laut MEDLINE: Glioblastoma, Prodrugs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaProdrugsHumansTemozolomideNitric OxidePolymersAntineoplastic Agents, AlkylatingDacarbazine

Stichwörter der Autor:innen

MTICglioblastomanitric oxidepolymer–drug conjugatestemozolomide

Substanzen

TemozolomideNitric Oxide5-(3-methyl-1-triazeno)imidazole-4-carboxamidePolymersAntineoplastic Agents, AlkylatingProdrugsDacarbazine

Autor:innen und Institutionen

  • MOE Key Laboratory of High Performance Polymer Materials and Technology, and Department of Polymer Science & Engineering, School of Chemistry & Chemical Engineering, Nanjing University, Nanjing 210023, China.
  • Hunan Provincial Key Laboratory of Environmental Catalysis & Waste Regeneration, College of Materials and Chemical Engineering, Hunan Institute of Engineering, Xiangtan 411104, Hunan, China.

ORCID-Profile: Fude Feng

Förderung

  • Natural Science Foundation of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Du, K., Li, X., & Feng, F. (2024). Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme. ACS Applied Bio Materials, 7(3), 1810-1819. https://doi.org/10.1021/acsabm.3c01219

Vancouver

Du K, Li X, Feng F. Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme. ACS Applied Bio Materials. 2024;7(3):1810-1819. doi:10.1021/acsabm.3c01219

BibTeX
@article{Du2024,
  author = {Du, Ke and Li, Xiao and Feng, Fude},
  title = {Polymer–Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme},
  journal = {ACS Applied Bio Materials},
  year = {2024},
  volume = {7},
  number = {3},
  pages = {1810--1819},
  doi = {10.1021/acsabm.3c01219}
}
Kostenlos starten →